New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 25, 2014
08:03 EDTSPNCSpectranetics price target raised to $30 from $24 at Stifel
Stifel increased its price target on Spectranetics after the company announced positive results from its EXCITE ISR clinical trial. The firm sees the results as a major milestone for Spectranetics and keeps a Buy rating on the shares.
News For SPNC From The Last 14 Days
Check below for free stories on SPNC the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 24, 2014
17:23 EDTSPNCVisium Asset Management reports 5.2% passive stake in Spectranetics
Subscribe for More Information
16:23 EDTSPNCSpectranetics sees FY14 EPS (36c)-(32c), consensus (30c)
Subscribe for More Information
16:21 EDTSPNCSpectranetics reports Q2 EPS (16c), consensus (8c)
Subscribe for More Information
07:57 EDTSPNCSpectranetics remains a top small cap pick, says Canaccord
Subscribe for More Information
July 23, 2014
18:34 EDTSPNCOn The Fly: After Hours Movers
UP AFTER EARNINGS: Fortinet (FTNT), up 7.8%... Hanesbrands (HBI), up 5.4%... 8x8 (EGHT), up 5.1%... Infinera (INFN), up 4.9%... Facebook (FB), reverses and is now trading up 5.1% following second quarter earnings conference call. NOTABLE: Twitter (TWTR), up 1.7%, LinkedIn (LNKD), up marginally, and Yelp (YELP), up 1.6% after Facebook reports second quarter results. ALSO HIGHER: Spectranetics (SPNC), up 7.1% after receiving FDA clearance for atherectomy products, Turbo-Tandem and Turbo Elite... Ariad Pharmaceuticals (ARIA), up 7.1%... Jamba (JMBA), up 3.8% after Engaged Capital reports stake in the company and announced that they had discussions with management. DOWN AFTER EARNINGS: AT&T (T), down 1.2%... Angie's List (ANGI), down 16.4%... Tripadvisor (TRIP), down 11.5%... Orchids Paper (TIS), down 7.4%... Cirrus Logic (CRUS), down 6.6%... Cliffs Natural (CLF), down 1.2%... Teradyne (TER), down 4%. ALSO LOWER: Kandi Technologies (KNDI), down 3.8% after being mentioned negatively in a Seeking Alpha blog post.
16:46 EDTSPNCSpectranetics receives FDA clearance of peripheral laser atherectomy devices
Subscribe for More Information
16:07 EDTSPNCSpectranetics trading halted, pending news
July 21, 2014
07:50 EDTSPNCSpectranetics to meet or beat, remains a top small-cap idea, says Canaccord
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use